http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013134052-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-50
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2013-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a033a2dcca9194ab9275d351baaa5193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c58eeab9c64fe98a12ad35e1c285fb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7cc61ffec7776543e622895865e1f13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e14c1e05f23b35f7598eb2f0e0645b2e
publicationDate 2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013134052-A1
titleOfInvention Il-17 antibody formulation
abstract The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019027828-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-033824-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022135395-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016103153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019123283-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102506173-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170095878-A
priorityDate 2012-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008068246-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007070750-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21863217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451197127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454013444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226453182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27447

Total number of triples: 58.